You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sitravatinib

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cervical Cancer Trial (Tislelizumab, Sitravatinib)

Not yet recruiting
  • Metastatic Cervical Cancer
  • (no location specified)
Jan 31, 2023

Recurrent Endometrial Cancer, Solid Tumors Trial in Pittsburgh (pembrolizumab, Sitravatinib)

Recruiting
  • Recurrent Endometrial Cancer
  • Solid Tumors
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 12, 2022

NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +8 more
  • New Haven, Connecticut
    Yale University
Oct 26, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +2 more
  • Nivolumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Carcinoma, Hepatocellular, Gastric/Gastroesophageal Junction Cancer Trial in China (Sitravatinib, Sitravatinib plus

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Gastric/Gastroesophageal Junction Cancer
  • Sitravatinib
  • +2 more
  • Hefei, Anhui, China
  • +17 more
Jul 28, 2022

Healthy Adults Trial in Madison (Sitravatinib, Pantoprazole, Famotidine)

Completed
  • Healthy Adults
  • Sitravatinib
  • +2 more
  • Madison, Wisconsin
    Covance Clinical Research Unit Inc.
Aug 24, 2022

Metastatic Breast Cancer Trial in Shanghai (Sitravatinib, Tislelizumab, Nab-paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Sitravatinib
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer
Jul 31, 2022

Healthy Adults Trial in Dallas (sitravatinib)

Completed
  • Healthy Adults
  • sitravatinib
  • Dallas, Texas
    Covance Clinical Research Unit, Inc.
Apr 4, 2022

Lung Cancer, Small Cell Trial in Hangzhou (Tislelizumab, Sitravatinib)

Recruiting
  • Lung Cancer, Small Cell
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 13, 2022

Tumor Trial in Nedlands (Sitravatinib)

Completed
Has Results
  • Tumor
  • Sitravatinib
  • Nedlands, Western Australia, Australia
    Linear Clinical Research Pty Lt(LCR)
Nov 5, 2021

Hepatic Impairment Trial in United States (sitravatinib)

Recruiting
  • Hepatic Impairment
  • sitravatinib
  • Tustin, California
  • +4 more
Apr 4, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2022

Advanced Solid Tumors Trial in Australia, China (Sitravatinib)

Completed
  • Advanced Solid Tumors
  • Sitravatinib
  • Blacktown, New South Wales, Australia
  • +16 more
Jan 10, 2023

Clear-Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab, Ipilimumab)

Enrolling by invitation
  • Clear-Cell Renal Cell Carcinoma
  • Sitravatinib
  • +2 more
  • Houston, Texas
    MD Anderson
Jan 23, 2022

Advanced or Metastatic Solid Malignancies Trial in United States (Sitravatinib, Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Advanced or Metastatic Solid Malignancies
  • Sitravatinib
  • +4 more
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

NSCLC Trial in Shanghai (Tislelizumab, Sitravatinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 15, 2021

Melanoma Trial in Beijing (sitravatinib, tislelizumab)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 2, 2021

NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Sep 6, 2023

Breast Cancer Stage IV, Triple Negative Breast Cancer, Breast Tumors Trial in Houston (Sitravatinib)

Recruiting
  • Breast Cancer Stage IV
  • +3 more
  • Sitravatinib
  • Houston, Texas
    Baylor College of Medicine
Jun 1, 2021

Clear Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab)

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Apr 27, 2021

Esophageal Squamous Cell Carcinoma Trial in China (Sitravatinib, Tislelizumab, Docetaxel)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Sitravatinib
  • +3 more
  • Hefei, Anhui, China
  • +29 more
Jul 28, 2022

Squamous Cell Carcinoma, Head And Neck, Squamous Cell Carcinoma Mouth, Squamous Cell Carcinoma of the Oral Cavity Trial in

Completed
  • Squamous Cell Carcinoma, Head And Neck
  • +2 more
  • Sitravatinib
  • Nivolumab
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Mar 30, 2021

Advanced Biliary Tract Cancer Trial in Seoul (Sitravatinib, Tislelizumab)

Unknown status
  • Advanced Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 23, 2021

Hepatocellular Carcinoma Trial in Worldwide (Sitravatinib, Tislelizumab, sitravatinib-matching )

Not yet recruiting
  • Hepatocellular Carcinoma
  • Sitravatinib
  • +3 more
  • Bengbu, Anhui, China
  • +81 more
Feb 1, 2023

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Ureter Trial in United States (Sitravatinib, Nivolumab,

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Sitravatinib
  • +3 more
  • Tucson, Arizona
  • +33 more
May 21, 2021